Biphasic effect of prostaglandin E1 on the severity of acute pancreatitis induced by a closed duodenal loop in rats

Pancreas

Volumn 12, Issue 2, 1996, Pages 159-164

  Pozsar J ^a   Berger, Z ^a   Simon, K ^a   Kovacsai A ^a   Marosi, E ^a   Pap, A ^a  

^a Szent Imre Hospital   (Hungary)

Author keywords

Acute pancreatitis; Closed duodenal loop; Prostaglandin E1; Rat

Indexed keywords

PROSTAGLANDIN E1;

ACUTE PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA CONTENT; DOSE RESPONSE; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RAT; SCORING SYSTEM;

EID: 0030031490     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199603000-00009     Document Type: Article

References (28)

1. Goerig M, Habenicht AJR, Schettler G. Eicosanoide und Phospholipasen. Klin Wochenschr 1985;63:293-311.
2. Van Oijen B, Kort WJ, Ziljstra FJ, Vincent JE, Wilson JHP, Westbvroek DL. Prostanoid imbalance in acute experimental pancreatitis in rats. Scand J Gastroenterol 1988;23:192-8.
3. Manabe T, Steer ML. Protective effects of PGE2 on diet-induced acute pancreatitis in mice. Gastroenterology 1980; 78:777-81.
4. Glazer G, Bennett A. Prostaglandin release in canine acute haemorrhagic pancreatitis. Gut 1976;17:22-6.
5. Yokota M, Kabayashi J, Sakon M, et al. The possible involvement of platelet activation in endotoxin-induced renal insufficiency in a rabbit model. Jpn J Surg 1991;21(5):542-6.
6. Tate GA, Mandell BF, Schumacher HR, Zurier RB. Suppression of acute inflammation by 15-methyl-prostaglandin E1. Lab Invest 1988;59:192-9.
7. Fantone JC, Kinnes DA. Prostaglandin E1 and prostaglandin I2 modulation of superoxide production by human neutrophils. Biochem Biophys Res 1983;113:506.
8. Jaworek J, Konturek SJ. Effects of prostaglandins (PG) of E, F and I series leukotrienes (LT) and platelet activating factor (PAF) on amylase release from isolated pancreatic acini. Digestion 1992;52:2 (abstr 61b).
9. Stanfield NJ, Kakkar VV. Prostaglandins and acute pancreatitis - experimental and clinical studies. Br J Surg 1983;70: 573-6.
10. Olazaba A. Prostaglandin E2 and I2 treatment of acute experimental pancreatitis in rats. Pancreas 1986;1:529-35.
11. Crocket KV, Bracket K, Crocket A, Jacovson ED, Rao SS, Joffe SN. Prostaglandin E1 treatment in experimental acute pancreatitis in the rat. Eur Surg Res 1984;16:265-73.
12. Nevalainen TJ, Seppa A. Acute pancreatitis caused by closed duodenal loop in the rat. Scand J Gastroenterol 1975; 10:521-7.
13. Schneider WC. Determination of nucleic acids in tissue by pentose analysis. Methods Enzymol 1957;3:680-4.
14. Giles KW, Myers A. An improved diphenylamin method for the estimation of deoxyribonucleic acid. Nature (London) 1965;206:93.
15. Ceska M, Brown B, Birath K. A new rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions. Clin Chim Acta 1969; 26:437-44.
16. Erlanger BF, Kokowsky W, Chen W. The preparation and properties of two new chromogenic substrates of trypsin. Arch Biochem Biophys 1961;95:271-8.
17. Goa J. Micro biuret method for protein determination: determination of total protein in cerebrospinal fluid. Scand J Clin Invest 1953;5:218-22.
18. Masaki N, Ohta Y, Shirataki H, et al. Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury. Gastroenterology 1992;102:572-6.
19. Nagata S, Kebo DK, Kunlkel S, Glovsky MM. Effect of adenylate cyclase activators on C5a induced human neutrophyl aggregation, enzyme release and superoxide production. Int Arch Allergy Appl Immunol 1992;97:194-9.
20. Ney P, Braun M, Szymanski C, Burch L, Schror K. Antiplatelet, antineutrophyl and vasodilatating properties of 13,14-dihydro-PGE1 (PGEO) - an in vivo metabolite of PGE1 in man. Eicosanoids 1991;4:177-84.
21. Raper RF, Sibbald WJ, Hobson J, Rutledge FS. Effect of PGE1 on altered distribution of regional blood flow in hyperdynamic sepsis. Chest 1991;100:1703-11.
22. Knoefel WT, Kollias N, Warshaw AL, Nishioka NS, Waldner H, Rattner DW. Pancreatic microperfusion in experimental pancreatitis of increasing severity. Digestion 1991; 49:31 (abstr72).
23. Van Ooijen B, Ouwendijk RJT, Kort WJ, et al. Raised plasma thromboxan B2 levels in experimental acute necrotizing pancreatitis in rats. Scand J Gastroenterol 1988;23: 188-92.
24. Kiviniemi H, Ram OJ. The behavior of prostanoids during the course of acute experimental pancreatitis in rats. Res Exp Med 1986;186:449-53.
25. Berger Z, Balint GA, Pap A, Karacsony G, Varro V. Prostaglandin F2 alpha and prostacyclin tissue levels in early phases of trypsin-induced acute pancreatitis in rats. Pancreas 1989;4:295-9.
26. Van Ooijen, Kort WJ, Tinga CJ, Wilson P. Significance of thromboxan A2 and prostaglandin I2 in acute necrotizing pancreatitis. Dig Dis Sci 1990;35:1078-84.
27. Buscail L, Senegas-Balas F, Balas D, Bouisson M, Bertrand C, Ribet A. Protective effect of misoprostol, a synthetic prostaglandin E1 analog, on cerulein-induced acute pancreatitis in rats. Pancreas 1990;5:171-6.
28. Buscail L, Senegas-Balas F, Balas D, Bouisson M, Bertrand C, Ribet A. Protective effect of misoprostol, a synthetic prostaglandin E1 analog, on experimental pancreatitis induced by pancreatic duct ligation in rat. Pancreas 1989;4: 715-23.